Chiesi is hoping real world evidence will show its latest COPD triple therapy can help ... beta adrenoceptor agonist (LABA) and a long-acting muscarinic antagonist (LAMA) in a single delivery ...

Trelegy – based on corticosteroid fluticasone furoate, LAMA umeclidinium and LABA vilanterol and approved ... It already competes with a triple COPD therapy from Chiesi called Trimbow ...

Individuals with COPD have an increased risk of mortality from exposure to extreme temperatures, both heat and cold, as well as from exposure to air pollution. Climate change is affecting the health ...

With seating for up to 5 passengers and 2 crew members, the EC135 P2 is the perfect solution for corporate travel, VIP transport, and emergency medical services. And with the optional Cineflex camera ...

Radiation therapy to the pelvis can cause sexual problems for many women with cancer. These problems can be temporary or last long-term after treatment has finished. Radiation to other body parts, ...

When the Dalai Lama turns 90 in July, the Buddhist monk, who for many exiled Tibetans personifies dreams of a free homeland, will ask if they want a successor. For the charismatic Nobel Peace ...

Concerns about the safety of long-acting β2-agonist (LABA) therapy, has led to the appearance of multiple publications and recommendations. This review critically examines the available clinical ...

In most cases, this would be correct. However, once-off spirometry doesn't always expose conditions like mild to moderate COPD. In some cases, the FEV1/FVC ratio can veer between normal and abnormal ...